About 90 % of all pancreatic cancers are ductal adenocarcinomas with an overall 5-year survival rate of less than 5%. The explanation as to why most pancreatic cancers arise from ductal cells has only come to light in the past few years. Most knowledge has been found at the molecular level which shows an increasing number of genetic and epigenetic alterations, in particular on growth factors and related pathways. Furthermore, basic researchers have identified molecular alterations which render cancer cells capable of invading the perineurium and the retroperitoneal space, thus, explaining the high rate of local recurrence and severe pai
Background: Pancreatic cancer is the fourth most common cause of mortality due to cancer, globally. ...
Malignancy of the pancreas is a widespread disease with horrible predictions and requires new sympto...
Pancreatic cancer is projected to become the second leading cause of cancer-related death in the Uni...
With less than a 5% survival rate pancreatic adenocarcinoma (PDAC) is almost uniformly lethal. In or...
With less than a 5% survival rate pancreatic adenocarcinoma (PDAC) is almost uniformly lethal. In or...
The diagnosis of pancreatic cancer is devastating for patients and their relatives as the incidence ...
Some cases of pancreatic cancer (PC) are described to cluster within families. With the exception of...
Abstract Cancer of the exocrine pancreas represents the fifth leading cause of cancer death in the W...
Pancreatic cancer is a deadly disease. Discovery of the mutated genes that cause the inherited form(...
The number of cases of pancreatic cancers in 2019 in Poland was 3852 (approx. 2% of all cancers). Th...
Pancreatic cancer is a devastating disease. At time of diagnosis the disease is usually advanced and...
The prospect that pancreatic cancer will be the second most common cause of cancer death by 2030 is ...
The incidence of pancreatic cancer has increased steadily in most of the world and now this type of ...
Pancreatic cancer has a dismal prognosis. We have studied this cancer through the eyes of Charles Da...
N Context.—The introduction of genome- and epigenome-wide screening techniques has dramatically impr...
Background: Pancreatic cancer is the fourth most common cause of mortality due to cancer, globally. ...
Malignancy of the pancreas is a widespread disease with horrible predictions and requires new sympto...
Pancreatic cancer is projected to become the second leading cause of cancer-related death in the Uni...
With less than a 5% survival rate pancreatic adenocarcinoma (PDAC) is almost uniformly lethal. In or...
With less than a 5% survival rate pancreatic adenocarcinoma (PDAC) is almost uniformly lethal. In or...
The diagnosis of pancreatic cancer is devastating for patients and their relatives as the incidence ...
Some cases of pancreatic cancer (PC) are described to cluster within families. With the exception of...
Abstract Cancer of the exocrine pancreas represents the fifth leading cause of cancer death in the W...
Pancreatic cancer is a deadly disease. Discovery of the mutated genes that cause the inherited form(...
The number of cases of pancreatic cancers in 2019 in Poland was 3852 (approx. 2% of all cancers). Th...
Pancreatic cancer is a devastating disease. At time of diagnosis the disease is usually advanced and...
The prospect that pancreatic cancer will be the second most common cause of cancer death by 2030 is ...
The incidence of pancreatic cancer has increased steadily in most of the world and now this type of ...
Pancreatic cancer has a dismal prognosis. We have studied this cancer through the eyes of Charles Da...
N Context.—The introduction of genome- and epigenome-wide screening techniques has dramatically impr...
Background: Pancreatic cancer is the fourth most common cause of mortality due to cancer, globally. ...
Malignancy of the pancreas is a widespread disease with horrible predictions and requires new sympto...
Pancreatic cancer is projected to become the second leading cause of cancer-related death in the Uni...